This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

OM202JP Clinical Study of KNP2002

Sponsored by KinoPharma Inc.

About this trial

Last updated 2 years ago

Study ID

OM202JA

Status

Recruiting

Type

Interventional

Phase

Phase 2

Placebo

No

Accepting

18-75 Years
15 to 49 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended a year ago

What is this trial about?

The goal of this clinical trial is to evaluate safety and efficacy of KNP2002 in patients with common warts aged 15 to 50 years old.

What are the participation requirements?

Yes

Inclusion Criteria

- Subjects aged 15 to 49 years old

- Subjects with common warts on the upper or lower limb

- Subjects who agree to contraception from obtaining consent to 4 weeks after the end of administration

- Subjects who have given their voluntary written consent to participate in this clinical trial

No

Exclusion Criteria

- Subjects with 5 or more warts on the upper or lower limbs

- Subjects who are scheduled to undergo treatment such as physical therapy or chemotherapy for warts

- Subjects with a history of allergy to topical skin preparations

- Subjects with a history of malignant tumor within 5 years before administration of study drug

- Subjects with any of the following diseases: Malignant tumor; Serious heart disease; Poorly controlled diabetes/hypertension

- Women who are pregnant, may become pregnant, or are breastfeeding

Locations

Location

Status

Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting